Is HQH above its 150-day moving average?

HQH is currently above its 150-day moving average by 7.37%. The MA150 sits at $18.12.

What is HQH's RSI right now?

HQH's 14-period RSI is 55.6. This is in a neutral zone (30–70).

Is HQH's MACD bullish or bearish?

HQH's MACD histogram reads -0.0441. A negative histogram means short-term momentum is leaning bearish.

How are HQH's technical signals calculated?

Scanance computes HQH's technicals daily after market close from end-of-day OHLCV data. MA150 and MA200 are simple moving averages. RSI uses Wilder's 14-period smoothing. MACD uses 12/26/9 exponential moving averages. Volume ratio compares current volume to the 20-day average.

Scanance does not provide investment advice. The technical readouts on this page are pattern matches against deterministic indicator rules — they are not buy or sell recommendations. Always do your own research and consider consulting a licensed financial professional before making any trade.

HQ

Abrdn Healthcare Investors

HQHFinancial ServicesNASDAQ

Asset Management

PriceMA150MA200

Loading chart…

End-of-day data · ScananceOpen live chart on TradingView ↗

Indicator snapshot

MA150+7.37%

$18.12

Price above medium-term moving average.

MA200+11.12%

$17.50

Above long-term trend line.

RSI-14neutral

55.6

Balanced. Not overbought, not oversold.

MACDnegative

-0.0441

Histogram negative — downward momentum.

Financials · Annual

Revenue

$99.8M

-46.5% YoY

Net Income

$98.6M

-46.7% YoY

Scan Results

Daily timeframe

DateIndicatorDetails

About Abrdn Healthcare Investors

Headquartered within the financial services sector, Abrdn Healthcare Investors focuses on Asset Management services and products. Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. Valued at $1.11B, HQH is a small-cap name in its sector. The fund invests in public equity markets across the globe.

Key stats

Market Cap$1.11B

P/E (TTM)12.08

EPS$1.61

Beta0.77

52W Change+26.1%

Dividend Yield11.93%

ROE9.2%

Analysis

Abrdn Healthcare Investors reports $59 in cash and $0 in total debt. Return on equity stands at 9.2%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from -$192.3M (2022) to $99.8M (2025), reflecting a 152% increase over the period.

Investors considering Abrdn Healthcare Investors should weigh the typical risks associated with HQH's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing HQH.

Links

Abrdn Healthcare Investors

News & analytics is part of Premium.

Technical readouts are part of Premium.